This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Q. M.
Right arrow Articles by Hale, J. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Q. M.
Right arrow Articles by Hale, J. E.

 Previous Article  |  Next Article 

J Virol, February 1998, p. 1683-1687, Vol. 72, No. 2
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Enzymatic Characterization of Refolded Human Rhinovirus Type 14 2A Protease Expressed in Escherichia coli

Q. May Wang,* Robert B. Johnson, Gregory A. Cox, Elcira C. Villarreal, Lisa M. Churgay, and John E. Hale

Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285

Received 5 August 1997/Accepted 4 November 1997

Reported here is the production of recombinant human rhinovirus 14 (HRV14) 2A protease from bacterial cells transformed with a heat-inducible plasmid containing the HRV14 2A cDNA sequence. Overexpressed 2A protein partitioned into the inclusion bodies was solubilized in urea and then refolded in the presence of Zn2+. Transition metals were required for the restoration of 2A protease activity as a structural component, but appeared to be inhibitory if added exogenously once the enzyme was refolded. Based on the cleavage specificity studies, a colorimetric assay was developed for the highly purified HRV14 2A protease. A peptide with the sequence RKGDIKSY-p-nitroanilide was found to be cleaved by the 2A protease with a kcat/Km ratio of ~335 M-1s-1, which allows its activity to be measured continuously with a spectrophotometer or a microplate reader.


* Corresponding author. Mailing address: Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285. Phone: (317) 277-6975. Fax: (317) 276-1743. E-mail: qmwang{at}lilly.com.




This article has been cited by other articles:

  • Wang, Q. M., Johnson, R. B., Jungheim, L. N., Cohen, J. D., Villarreal, E. C. (1998). Dual Inhibition of Human Rhinovirus 2A and 3C Proteases by Homophthalimides. Antimicrob. Agents Chemother. 42: 916-920 [Abstract] [Full Text]